Congressional trades by ticker
JNJ congressional trades
Johnson & Johnson (JNJ) appears in 67 congressional disclosure rows from 24 members of Congress in 2025–2026 periodic reports: 30 purchases and 37 sales, with trade dates from Mar 15, 2023 to Aug 27, 2026. Thomas Kean reported the most, with 7 rows. The median gap between trade date and filing date is 27 days, and 11 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live JNJ portfolio or a trading signal.
- Verified rows
- 67
- Filers
- 24
- Buys / sells
- 30 / 37
- Disclosed range
- $496K – $2.0M
- sum of reported ranges
- Latest trade
- 2026-08-27
Verified JNJ congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 30 purchases and 37 sales. Reported owners: Self, Joint, Spouse, Dependent. Transaction dates run from 2023-03-15 to 2026-08-27.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Thomas Kean | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20035431 Filed 2026-09-12 | |
| John Boozman | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #6298991b-e48f-4b11-9bbb-dfc94a7e1b32 Filed 2026-09-11 | |
| Rich McCormick | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20035204 Filed 2026-08-14 | |
| Thomas Kean | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20035003 Filed 2026-07-15 | |
| Lloyd Doggett | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20034923 Filed 2026-07-06 | |
| Thomas Kean | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20035003 Filed 2026-07-15 | |
| Alan Armstrong | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Alan Armstrong | Johnson & Johnson Common Stock | Purchase | Self | $15,001 - $50,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Thomas Kean | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20034327 Filed 2026-04-13 | |
| John Boozman | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #e9d6ab5f-3a50-49bc-9f00-3ef4655045aa Filed 2026-04-14 | |
| Rich McCormick | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20033648 Filed 2026-04-07 | |
| Rich McCormick | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20033648 Filed 2026-04-07 | |
| Lloyd Doggett | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20034292 Filed 2026-04-06 | |
| Thomas Kean | Johnson & Johnson Common Stock | Sale | Self | $15,001 - $50,000 | #20034025 Filed 2026-02-19 | |
| Julie Johnson | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #20033789 Filed 2026-01-15 | |
| Lloyd Doggett | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20033713 Filed 2026-01-02 | |
| Thomas Kean | Johnson & Johnson Common Stock | Sale | Self | $15,001 - $50,000 | #20033659 Filed 2025-12-19 | |
| Julie Johnson | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #20033611 Filed 2025-12-11 | |
| Rich McCormick | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20033610 Filed 2025-12-09 | |
| Lisa McClain | Johnson & Johnson Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | Johnson & Johnson Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | Johnson & Johnson Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Jared Moskowitz | Johnson & Johnson Common Stock | Sale | Dependent | $1,001 - $15,000 | #20033421 Filed 2025-11-22 | |
| Jared Moskowitz | Johnson & Johnson Common Stock | Sale | Dependent | $1,001 - $15,000 | #20033421 Filed 2025-11-22 | |
| Valerie Hoyle | Johnson & Johnson Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| Kelly Morrison | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20032061 Filed 2025-09-11 | |
| Julie Johnson | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #20032066 Filed 2025-09-11 | |
| Lisa McClain | Johnson & Johnson Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030932 Filed 2025-09-12 | |
| Thomas Kean | Johnson & Johnson Common Stock | Sale | Self | $15,001 - $50,000 | #20030946 Filed 2025-08-20 | |
| Lisa McClain | Johnson & Johnson Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Johnson & Johnson Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| C. Franklin | Johnson & Johnson Common Stock | Sale | Joint | $15,001 - $50,000 | #20030670 Filed 2025-07-14 | |
| Pete Sessions | Johnson & Johnson Common Stock | Sale | Spouse | $15,001 - $50,000 | #20030544 Filed 2025-06-21 | |
| Lloyd Doggett | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20030618 Filed 2025-07-07 | |
| Gilbert Cisneros | Johnson & Johnson Common Stock | Purchase | Self | $15,001 - $50,000 | #20030461 Filed 2025-06-06 | |
| Jefferson Shreve | Johnson & Johnson Common Stock | Sale | Self | $50,001 - $100,000 | #20030387 Filed 2025-06-22 | |
| Marjorie Greene | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20030295 Filed 2025-05-06 | |
| Gilbert Cisneros | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20030288 Filed 2025-05-06 | |
| Bruce Westerman | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20030332 Filed 2025-05-12 | |
| Josh Gottheimer | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #20030338 Filed 2025-05-14 | |
| Robert Bresnahan | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20030238 Filed 2025-04-28 | |
| Julie Johnson | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #20030296 Filed 2025-05-14 | |
| Gilbert Cisneros | Johnson & Johnson Common Stock | Purchase | Self | $15,001 - $50,000 | #20029026 Filed 2025-04-07 | |
| George Whitesides | Johnson & Johnson Common Stock | Sale | Self | $100,001 - $250,000 | #20027982 Filed 2025-04-23 | |
| Sheri Biggs | Johnson & Johnson Common Stock | Sale | Spouse | $15,001 - $50,000 | #20032149 Filed 2025-10-05 | |
| Josh Gottheimer | Johnson & Johnson Common Stock | Sale | Joint | $1,001 - $15,000 | #20029083 Filed 2025-04-10 | |
| Jefferson Shreve | Johnson & Johnson Common Stock | Purchase | Self | $15,001 - $50,000 | #20029038 Filed 2025-04-11 | |
| Lloyd Doggett | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20029088 Filed 2025-04-07 | |
| Bruce Westerman | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20030146 Filed 2025-04-16 | |
| Jefferson Shreve | Johnson & Johnson Common Stock | Purchase | Self | $15,001 - $50,000 | #20027879 Filed 2025-03-09 | |
| Gilbert Cisneros | Johnson & Johnson Common Stock | Sale | Self | $1,001 - $15,000 | #20026726 Filed 2025-02-11 | |
| Josh Gottheimer | Johnson & Johnson Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026732 Filed 2025-02-10 | |
| Josh Gottheimer | Johnson & Johnson Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026732 Filed 2025-02-10 | |
| Josh Gottheimer | Johnson & Johnson Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026732 Filed 2025-02-10 | |
| Marjorie Greene | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20026658 Filed 2025-01-27 | |
| Marjorie Greene | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20026658 Filed 2025-01-27 | |
| Marjorie Greene | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20026658 Filed 2025-01-27 | |
| Kevin Hern | Johnson & Johnson Common Stock | Sale | Joint | $100,001 - $250,000 | #20026597 Filed 2025-01-15 | |
| Josh Gottheimer | Johnson & Johnson Common Stock | Purchase | Joint | $1,001 - $15,000 | #20026533 Filed 2025-01-14 | |
| Lloyd Doggett | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20026535 Filed 2025-01-08 | |
| Virginia Foxx | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20026516 Filed 2025-01-06 | |
| Tommy Tuberville | Johnson & Johnson Common Stock | Sale | Joint | $15,001 - $50,000 | #2b076d77-6bc1-4b67-8be9-8f45a787479f Filed 2026-08-05 | |
| Tommy Tuberville | Johnson & Johnson Common Stock | Sale | Joint | $15,001 - $50,000 | #cce52b36-d00c-4710-a8ee-e84893fb4be1 Filed 2026-08-05 | |
| Valerie Hoyle | Johnson & Johnson Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 | |
| Ritchie Torres | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20030930 Filed 2025-08-20 | |
| C. Franklin | Johnson & Johnson Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030494 Filed 2025-07-03 | |
| Rich McCormick | Johnson & Johnson Common Stock | Purchase | Self | $1,001 - $15,000 | #20030699 Filed 2025-09-17 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
JNJ disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Thomas Kean's JNJ trades | 7 | 0 | 7 | 2026-08-27 |
| Josh Gottheimer's JNJ trades | 6 | 4 | 2 | 2025-04-09 |
| Lisa McClain's JNJ trades | 6 | 3 | 3 | 2025-10-31 |
| Lloyd Doggett's JNJ trades | 6 | 6 | 0 | 2026-06-09 |
| Rich McCormick's JNJ trades | 5 | 2 | 3 | 2026-07-30 |
| Gilbert Cisneros's JNJ trades | 4 | 2 | 2 | 2025-05-30 |
| Julie Johnson's JNJ trades | 4 | 0 | 4 | 2025-12-18 |
| Marjorie Greene's JNJ trades | 4 | 4 | 0 | 2025-05-05 |
| Jefferson Shreve's JNJ trades | 3 | 2 | 1 | 2025-05-12 |
| Alan Armstrong | 2 | 2 | 0 | 2026-03-30 |
| Bruce Westerman | 2 | 1 | 1 | 2025-04-21 |
| C. Franklin | 2 | 1 | 1 | 2025-06-16 |
| Jared Moskowitz | 2 | 0 | 2 | 2025-10-10 |
| John Boozman | 2 | 0 | 2 | 2026-08-20 |
| Tommy Tuberville | 2 | 0 | 2 | 2024-10-29 |
| Valerie Hoyle | 2 | 1 | 1 | 2025-09-23 |
| George Whitesides | 1 | 0 | 1 | 2025-03-24 |
| Kelly Morrison | 1 | 0 | 1 | 2025-08-19 |
| Kevin Hern | 1 | 0 | 1 | 2024-12-31 |
| Pete Sessions | 1 | 0 | 1 | 2025-06-12 |
| Ritchie Torres | 1 | 1 | 0 | 2024-09-26 |
| Robert Bresnahan | 1 | 0 | 1 | 2025-04-08 |
| Sheri Biggs | 1 | 0 | 1 | 2025-03-19 |
| Virginia Foxx | 1 | 1 | 0 | 2024-12-06 |
How long disclosure took
Days from trade date to filing date for 67 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 8
- 16–30 days
- 34
- 31–45 days
- 14
- Over 45 days
- 11
- Median / longest
- 27d / 917d
Source documents
56 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #20035431Filed 2026-09-12 · 1 row
- #6298991b-e48f-4b11-9bbb-dfc94a7e1b32Filed 2026-09-11 · 1 row
- #20035204Filed 2026-08-14 · 1 row
- #2b076d77-6bc1-4b67-8be9-8f45a787479fFiled 2026-08-05 · 1 row
- #cce52b36-d00c-4710-a8ee-e84893fb4be1Filed 2026-08-05 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 2 rows
- #20035003Filed 2026-07-15 · 2 rows
- #20034923Filed 2026-07-06 · 1 row
- #e9d6ab5f-3a50-49bc-9f00-3ef4655045aaFiled 2026-04-14 · 1 row
- #20034327Filed 2026-04-13 · 1 row
- #20033648Filed 2026-04-07 · 2 rows
- #20034292Filed 2026-04-06 · 1 row
44 older filings are linked from the transaction table.
What JNJ filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- Johnson & Johnson financials and filings
Audited SEC figures, what moves JNJ, and primary sources.
Compare JNJ vs LLY side by side
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
Sep 22, 2026
Meta jumped 11%. What must happen next to justify the price?A member research report on Meta’s AI rally: Muse, subscription economics, the cash-flow burden, legal costs and the earnings assumptions behind the new price.
Sep 9, 2026
Seagate: More Terabytes, Better EconomicsA retrospective case study of Seagate’s capacity-density thesis as of January 28, 2026, separating known qualifications and financials from an uncertain next phase.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
JNJ congressional trades — FAQ
Who in Congress traded JNJ?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 67 verified JNJ rows from 24 members: Alan Armstrong, Bruce Westerman, C. Franklin, George Whitesides, and 20 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current JNJ holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are JNJ amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000; $50,001 - $100,000; $100,001 - $250,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is JNJ congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (176 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded JNJ.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-10-03. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported JNJ and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included